Weifa ASA – Strategy, SWOT and Corporate Finance Report
- Pages: 41
- Published: May 2017
- Report Code: MLPH82367FSA
Weifa ASA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Weifa ASA (Weifa), formerly Aqualis ASA, is a pharmaceutical company that conducts the research and development, manufacture, distribution and sales of pharmaceutical products, lifestyle products and solutions. The company has over the counter (OTC) pharmaceutical market in Norway offering products for pain relief; treatment of cough and colds; dermatology; Nutraceuticals; dietary supplements; and wound treatment among others. Its research and development activities focus on prescription drug products, OTC products and nutraceuticals. It offers products to consumers, customers and professional partners. The company has operational presence in Denmark, Iceland, Sweden and Finland. Weifa is headquartered in Oslo, Norway.
Scope
Detailed information on Weifa ASA required for business and competitor intelligence needs
A study of the major internal and external factors affecting Weifa ASA in the form of a SWOT analysis
An in-depth view of the business model of Weifa ASA including a breakdown and examination of key business segments
News about Weifa ASA, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Weifa ASA and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess Weifa ASA as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Weifa ASAs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Serodus ASA
Saipem Norge AS
Novartis Oncology
Lytix Biopharma AS
Halliburton AS
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.